@Oblomov21
If Ireland are currently doing 12-15 year olds, why aren't UK?
It is odd, Irelands rationale is the same as the rest of Europe - vaccines are safe in children, lots of evidence to show safety, whilst serious complications are rare, they do occur, and we don't know the impact of long term effects of COVID.
*
www2.hse.ie/screening-and-vaccinations/covid-19-vaccine/get-the-vaccine/deciding-on-vaccination-for-12-to-15-year-olds/
COVID-19 and children aged 12 to 15
Most children aged 12 to 15 who get COVID-19 have very mild symptoms or no symptoms.
But children who get COVID-19 need to isolate from other people even if their symptoms are mild. This is to stop the spread of the virus. They need to stay at home for at least 10 days from when they develop symptoms or test positive.
Serious illness is rare
It is rare that COVID-19 causes serious illness, hospitalisation or death in children.
The risk of a child being hospitalised because of COVID-19 is low, and the risk of any child needing intensive care treatment is extremely low.
Data from the United States shows that around 7 in 10 children admitted to hospital have an existing underlying condition.
In extremely rare cases COVID-19 can cause a condition called multisystem inflammatory syndrome in children (MIS-C).
MIS-C is also known as paediatric inflammatory multisystem syndrome (PIMS). It causes pneumonia, inflammation of the heart and difficulty breathing. It can cause death.
We don’t know yet if there is a risk of long-lasting side effects from COVID-19 in children. This is sometimes called 'long COVID'.
Evidence shows vaccines are safe
The vaccines being offered to children in Ireland aged 12 to 15 are the Pfizer/BioNTech and Moderna COVID-19 vaccines.
Both vaccines are approved by the European Medicines Agency (EMA) as safe and effective. They are recommended in Ireland by the National Immunisation Advisory Committee (NIAC).
Thousands of people worldwide have been vaccinated as part of clinical trials.
This includes:
more than 2,000 children aged 12 to 15 for the Pfizer clinical trial
3,700 children aged 12 to 17 for the Moderna clinical trial
No new safety concerns were reported in children aged 12 to 15 after these trials.